Search research articles
Contact Us
Filters
Showing results (191-200 of 224) with videos related to
Page
of 23
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
September 29, 2020
Efficacy of Pembrolizumab Monotherapy in Patients With or Without Brain Metastases From Advanced Non-Small Cell Lung Cancer With a PD-L1 Expression ≥50%
Giulio Metro, Giuseppe Luigi Banna, Diego Signorelli, et al.
Cancer Cell
|
July 2, 2021
Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer
Alfredo Addeo, Pankil K Shah, Natacha Bordry, et al.
Clinical Lung Cancer
|
November 9, 2020
Steroid Use Independently Predicts for Poor Outcomes in Patients With Advanced NSCLC and High PD-L1 Expression Receiving First-Line Pembrolizumab Monotherapy
Giannis Mountzios, Alessandro de Toma, Panagiota Economopoulou, et al.
Expert Review of Molecular Diagnostics
|
September 27, 2021
Liquid biopsy from research to clinical practice: focus on non-small cell lung cancer
Umberto Malapelle, Pasquale Pisapia, Alfredo Addeo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 28, 2022
UNcommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-Life Practice in First-LiNe Setting (UNICORN)
Jair Bar, Nir Peled, Shiruyeh Schokrpur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 25, 2023
Long-Term Outcomes and Molecular Correlates of Sotorasib Efficacy in Patients With Pretreated <i>KRAS</i> G12C-Mutated Non-Small-Cell Lung Cancer: 2-Year Analysis of CodeBreaK 100
Grace K Dy, Ramaswamy Govindan, Vamsidhar Velcheti, et al.
Future Oncology (London, England)
|
November 27, 2023
Long-term benefit of sotorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: plain language summary
Grace K Dy, Ramaswamy Govindan, Vamsidhar Velcheti, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 1, 2021
Prognostic Impact of KRAS G12C Mutation in Patients With NSCLC: Results From the European Thoracic Oncology Platform Lungscape Project
Stephen P Finn, Alfredo Addeo, Urania Dafni, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 1, 2025
Multimodality treatment in synchronous oligometastatic NSCLC: Analysis of the ETOP CHESS trial
Matthias Guckenberger, Isabelle Opitz, Tereza Dellaporta, et al.
Therapeutic Advances in Medical Oncology
|
June 20, 2022
Real-world experience with capmatinib in <i>MET</i> exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access program
Oliver Illini, Hannah Fabikan, Aurélie Swalduz, et al.
Page
of 23
Search research articles
Search
Showing results (191-200 of 224) with videos related to
Sort By:
Page
of 23
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
September 29, 2020
Efficacy of Pembrolizumab Monotherapy in Patients With or Without Brain Metastases From Advanced Non-Small Cell Lung Cancer With a PD-L1 Expression ≥50%
Giulio Metro, Giuseppe Luigi Banna, Diego Signorelli, et al.
Cancer Cell
|
July 2, 2021
Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer
Alfredo Addeo, Pankil K Shah, Natacha Bordry, et al.
Clinical Lung Cancer
|
November 9, 2020
Steroid Use Independently Predicts for Poor Outcomes in Patients With Advanced NSCLC and High PD-L1 Expression Receiving First-Line Pembrolizumab Monotherapy
Giannis Mountzios, Alessandro de Toma, Panagiota Economopoulou, et al.
Expert Review of Molecular Diagnostics
|
September 27, 2021
Liquid biopsy from research to clinical practice: focus on non-small cell lung cancer
Umberto Malapelle, Pasquale Pisapia, Alfredo Addeo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 28, 2022
UNcommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-Life Practice in First-LiNe Setting (UNICORN)
Jair Bar, Nir Peled, Shiruyeh Schokrpur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 25, 2023
Long-Term Outcomes and Molecular Correlates of Sotorasib Efficacy in Patients With Pretreated <i>KRAS</i> G12C-Mutated Non-Small-Cell Lung Cancer: 2-Year Analysis of CodeBreaK 100
Grace K Dy, Ramaswamy Govindan, Vamsidhar Velcheti, et al.
Future Oncology (London, England)
|
November 27, 2023
Long-term benefit of sotorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: plain language summary
Grace K Dy, Ramaswamy Govindan, Vamsidhar Velcheti, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 1, 2021
Prognostic Impact of KRAS G12C Mutation in Patients With NSCLC: Results From the European Thoracic Oncology Platform Lungscape Project
Stephen P Finn, Alfredo Addeo, Urania Dafni, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 1, 2025
Multimodality treatment in synchronous oligometastatic NSCLC: Analysis of the ETOP CHESS trial
Matthias Guckenberger, Isabelle Opitz, Tereza Dellaporta, et al.
Therapeutic Advances in Medical Oncology
|
June 20, 2022
Real-world experience with capmatinib in <i>MET</i> exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access program
Oliver Illini, Hannah Fabikan, Aurélie Swalduz, et al.
Page
of 23